Mitrabahtera Segara Sejati Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mitrabahtera Segara Sejati Tbk. trades at Rp2,620 (market cap 4.41T, 684.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Mitrabahtera Segara Sejati Tbk. is far larger — about 26.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Mitrabahtera Segara Sejati Tbk. is more actively traded (684.2K versus 96.7K). Which is the better fit depends on your goals.
| MBSS | OBAT | |
|---|---|---|
Market Cap | 4.41T | 167.37B |
Volume | 684.2K | 96.7K |
Lot | 6.84K | 967 |
Turnover | 1.78B | 23.82M |
Average Price | 2,599.41 | 246.34 |
Value | 1.78B | 23.82M |
Indicative Equilibrium Price | 2,620 | 248 |
Indicative Equilibrium Volume | 33 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitrabahtera Segara Sejati Tbk (the company) was established on 24 Mar 1994 based on Notaries Deed No. 107 and the deed of establishment was approved by the the Ministry of Justice dated Nov 6, 1996. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Fathiah Helmi, S.H., dated Dec 13, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on MBSS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →